Literature DB >> 9832330

Characterization of G protein-coupled receptors expressed by ECV304 human endothelial cells.

J Howl1, R M Mondszein, M Wheatley.   

Abstract

The aims of this study were to characterize G protein-coupled receptors endogenously expressed by ECV304 human endothelial cells, and to determine the utility of this transformed cell line as a vehicle for the expression of cloned receptors. Cellular responses to a broad range of agonists were determined by measuring changes in the intracellular content of second messengers (inositol phosphates and cyclic adenosine monophosphate). These studies identified H1 histamine receptors, P2U-purinoceptors and lysophosphatidic acid receptors which are functionally coupled to phosphoinositidase C. G protein-coupled receptors which bind adenosine (A2 receptor), calcitonin, and adrenaline (beta-adrenoceptor), and markedly stimulate adenylyl cyclase, are also endogenously expressed by ECV304. Agonists which did not stimulate ECV304 cells are: angiotensin II, angiotensin1-7, bombesin, bradykinin, desArg9-bradykinin, carbachol, endothelin-1, neurotensin, serotonin, substance K, substance P, thrombin and vasopressin. The rat Via vasopressin receptor was expressed by lipofection in two antibiotic-resistant clonal lines and expression confirmed by measuring agonist-induced changes in inostol phosphate production. We conclude that the ECV304 cell line is a suitable in vitro system to study the signal transduction pathways of some endogenous G protein-coupled receptors known to modulate endothelial function in vivo. ECV304 is also appropriate for the expression and functional characterization of cloned receptor proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832330     DOI: 10.3109/10623329809053402

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  2 in total

1.  Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.

Authors:  Michelle J Farquhar; Helen J Harris; Mandy Diskar; Sarah Jones; Christopher J Mee; Søren U Nielsen; Claire L Brimacombe; Sonia Molina; Geoffrey L Toms; Patrick Maurel; John Howl; Friedrich W Herberg; Sven C D van Ijzendoorn; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

2.  Bioportide: an emergent concept of bioactive cell-penetrating peptides.

Authors:  John Howl; Sabine Matou-Nasri; David C West; Michelle Farquhar; Jiřina Slaninová; Claes-Göran Ostenson; Matjaz Zorko; Pernilla Ostlund; Shant Kumar; Ulo Langel; Jane McKeating; Sarah Jones
Journal:  Cell Mol Life Sci       Date:  2012-04-20       Impact factor: 9.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.